Inventor · Foster City, CA, US

Kathryn S. Prickett

41Patents
28h-index
29Co-inventors
85Inventor score

Filing activity: Dec 19, 1986 → Apr 8, 2013

Most-cited inventions

PatentTitleAreaCited byStatus
US5011912A Hybridoma and monoclonal antibody for use in an immunoaffinity purification system Chemistry; Metallurgy 198 Expired
US6858576B1 Methods for regulating gastrointestinal motility Human Necessities 131 Expired
US6506724B1 Use of exendins and agonists thereof for the treatment of gestational diabetes mellitus Human Necessities 109 Expired
US6924264B1 Modified exendins and exendin agonists Human Necessities 107 Expired
US6703359B1 Inotropic and diuretic effects of exendin and GLP-1 Human Necessities 104 Expired
US4851341A Immunoaffinity purification system Emerging Cross-Sectional Technologies 95 Expired
US7297761B2 Pharmaceutical compositions containing exendins Human Necessities 95 Expired
US6087334A Anti-diabetic peptides Human Necessities 88 Expired
US7157555B1 Exendin agonist compounds Human Necessities 87 Expired
US6989366B2 Exendins, exendin agonists, and methods for their use Human Necessities 84 Expired
US7115569B2 Exendins, exendin agonists, and methods for their use Human Necessities 83 Expired
US7138375B2 Use of exendins and agonists thereof for lowering plasma lipid Human Necessities 75 Expired
US7928065B2 Methods of treatment using exendin peptides or GLP-1 peptides Human Necessities 61 Active
US7220721B1 Exendin agonist peptides Human Necessities 61 Expired
US7442680B2 Inotropic and diuretic effects of GLP-1 and GLP-1 agonists Human Necessities 59 Expired
US7223725B1 Exendin agonist compounds Human Necessities 52 Expired
US8445647B2 Modified exendins and exendin agonists Human Necessities 48 Active
US7419952B2 Use of exendins and agonists thereof to treat diabetes Human Necessities 45 Expired
US7700549B2 Exendin agonist analogs to treat diabetes Human Necessities 42 Active
US7691963B2 Exendins and exendin agonists modified with polyamino acids Human Necessities 42 Active
US7696161B2 Exendin agonist compounds Human Necessities 42 Active
US7452858B2 Treatment of gestational diabetes Human Necessities 42 Active
US8263550B2 Exendin agonist compounds Human Necessities 42 Active
US7608692B2 Exendins and exendin agonists modified with albumin Human Necessities 41 Active
US8057822B2 Modified exendins and exendin agonists Human Necessities 40 Active

Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.